| Followers | 5 |
| Posts | 973 |
| Boards Moderated | 0 |
| Alias Born | 03/03/2011 |
Sunday, April 03, 2011 10:13:54 AM
If I were running this business the Incentive for getting Marketing Approval for Copaxone would have been structured like this
Marketing approval before March 2012 - 300K shares
Marketing approval before March 2013 - 200K shares
Marketing approval before March 2015 - 100K shares
Currently, the only incentive to get this approval done as quickly as possible before 2015 is the immediate vesting of half of the shares on approval date.
The only reason I can think of is maybe FDA is years away from really approving this very complex drug.
My guess is copaxone is nowhere near approval before 2013 ??
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
